Introduction
Spinocerebellar ataxia type 1 (SCA1) is a member of the polyglutamine (polyQ) family of diseases, a group of dominantly inherited neurodegenerative disorders caused by the expansion of translated CAG trinucleotide repeats (Orr, 2012; Zoghbi and Orr, 2009) . In SCA1, the expanded polyQ tract resides near the N-terminus of the Ataxin-1 (Atxn1) protein (Banfi et al., 1994) . Although mutant Atxn1 is expressed throughout the brain, SCA1 is primarily characterized by the loss of cerebellar Purkinje cells and degeneration of the spinocerebellar tracts (Durr, 2010; Seidel et al., 2012) . While the exact molecular mechanisms underlying this selective neurodegeneration remain largely unknown, it has been suggested that the deregulation of gene expression programs may, in part, explain this cell and regionspecific vulnerability (Crespo-Barreto et al., 2010; Matilla-Duenas et al., 2010; Serra et al., 2004) .
Altered neuronal transcriptional activity is an early and persistent pathomolecular feature of most polyglutamine diseases (Orr and Zoghbi, 2007; Takahashi et al., 2010; Verbeek and van de Warrenburg, 2011) . Changes in the steady-state levels of numerous mRNA transcripts are seen in the cerebella of SCA1 patients and mouse models of the disease (Crespo-Barreto et al., 2010; Cvetanovic et al., 2011; Fernandez-Funez et al., 2000; Lin et al., 2000; Serra et al., 2004) . Since wild-type Atxn1 functions within a transcriptional repressor complex that includes the DNA binding protein Capicua (Lam et al., 2006) , transcriptional deregulation in SCA1 is thought to result from both a partial loss of Atxn1 function and a gain of toxic function in mutant Atxn1 (Lim et al., 2008; Orr, 2012) . In fact, SCA1 mouse models have reduced levels of the Atxn1-Capicua transcriptional repressor complex and a corresponding increase in the levels of some Atxn1-Capicua-regulated mRNAs (Crespo-Barreto et al., 2010) . However, the steady-state levels of numerous other mRNAs not directly regulated by the Atxn1-Capicua complex are also altered early in the pathogenesis of SCA1. This suggests that other cellular pathways may play key roles in the pathogenesis of SCA1.
MicroRNAs (miRNAs) are small non-coding RNAs employed to post-transcriptionally regulate the steady-state levels of mRNA transcripts in the cell (Kim et al., 2009) . Mounting evidence supports a role for microRNAs in the pathogenesis of SCA1. First, changes in steady-state levels of several miRNAs are observed in human SCA1 brains (Persengiev et al., 2011) . Second, disrupting miRNA biogenesis in Purkinje neurons leads to ataxia and cerebellar degeneration reminiscent of SCA1 and other dominantly inherited ataxias (Schaefer et Neurobiology of Disease 54 (2013) [456] [457] [458] [459] [460] [461] [462] [463] 
